Implications of the findings from the ESMO study of regulatory barriers, cost and availability of anti-cancer agents for European oncologists and patients
A. Eniu
Implications of the findings from the ESMO study of regulatory barriers, cost and availability of anti-cancer agents for European oncologists and patients
A. Eniu